Overall, these results indicated that chronic arsenic exposure and loss of KEAP1 function which maintains and activates NRF2 levels, augments NSCLC progression and metastatic potential via NRF2 and SOX9 signaling[71]. This evidence concerns the gene SOX9 and non-small cell lung carcinoma.